Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study

NCT04827056 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder (AUD)
Post Traumatic Stress Disorder (PTSD)

Interventions

DRUG: Placebo
DRUG: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg
DRUG: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg
PROCEDURE: Ethanol Infusion
BEHAVIORAL: PTSD Reactivity Condition
BEHAVIORAL: Alcohol Cue Reactivity

Sponsor

Pharmacotherapies for Alcohol and Substance Use Disorders Alliance

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]